Genetic landscape and biomarkers of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) has emerged as a major cause of cancer-related death. Its
mortality has increased in Western populations, with a minority of patients diagnosed at …
mortality has increased in Western populations, with a minority of patients diagnosed at …
Mechanisms of drug resistance in HCC
HCC comprises∼ 80% of primary liver cancer. HCC is the only major cancer for which death
rates have not improved over the last 10 years. Most patients are diagnosed with advanced …
rates have not improved over the last 10 years. Most patients are diagnosed with advanced …
EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma
European Association For The Study Of … - Journal of …, 2012 - journal-of-hepatology.eu
EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma
A Arzumanyan, HM Reis, MA Feitelson - Nature Reviews Cancer, 2013 - nature.com
Hepatocellular carcinoma (HCC) is a highly lethal cancer, with increasing worldwide
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …
[HTML][HTML] NANOG metabolically reprograms tumor-initiating stem-like cells through tumorigenic changes in oxidative phosphorylation and fatty acid metabolism
Stem cell markers, including NANOG, have been implicated in various cancers; however,
the functional contribution of NANOG to cancer pathogenesis has remained unclear. Here …
the functional contribution of NANOG to cancer pathogenesis has remained unclear. Here …
[HTML][HTML] EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma
EO for Research… - Journal of …, 2012 - Elsevier
EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
Chemotherapy for hepatocellular carcinoma: current status and future perspectives
M Ikeda, C Morizane, M Ueno… - Japanese journal of …, 2018 - academic.oup.com
Chemotherapy is one of the most important treatment modalities for advanced
hepatocellular carcinoma (HCC). On the basis of the results of two pivotal Phase III placebo …
hepatocellular carcinoma (HCC). On the basis of the results of two pivotal Phase III placebo …
[HTML][HTML] Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death
worldwide. Liver cancer is generally related to hepatitis B or C infection and cirrhosis …
worldwide. Liver cancer is generally related to hepatitis B or C infection and cirrhosis …
Functional and genetic deconstruction of the cellular origin in liver cancer
JU Marquardt, JB Andersen, SS Thorgeirsson - Nature Reviews Cancer, 2015 - nature.com
During the past decade, research on primary liver cancers has particularly highlighted the
uncommon plasticity of differentiated parenchymal liver cells (that is, hepatocytes and …
uncommon plasticity of differentiated parenchymal liver cells (that is, hepatocytes and …
Current strategy for staging and treatment: the BCLC update and future prospects
A Forner, ME Reig, CR de Lope… - Seminars in liver …, 2010 - thieme-connect.com
Staging and treatment indication are relevant topics in the management of patients with
hepatocellular carcinoma (HCC) and for optimal results, they have to take into account liver …
hepatocellular carcinoma (HCC) and for optimal results, they have to take into account liver …